Medical comms - Press Releases

Date	Title	Company
08-Nov-2019	BioNTech to Report Third Quarter 2019 Financial Results and Operational Progress on November 14, 2019	BioNTech SE
08-Nov-2019	Mallinckrodt Announces UVADEX® (Methoxsalen) Approved in Australia for use with the THERAKOS® CELLEX® Photopheresis System for Treatment of Chronic Graft Versus Host Disease (cGvHD) and Skin Manifestations of Cutaneous T-Cell Lymphoma (CTCL) in	Mallinckrodt plc
08-Nov-2019	Pooled Analyses of Bempedoic Acid Phase 3 LDL-C Lowering Clinical Trial Programme to be Presented at the American Heart Association 2019 Scientific Sessions	Daiichi Sankyo
08-Nov-2019	Bavarian Nordic Announces Submission of European Marketing Authorisation Applications for Investigational Ebola Vaccine Regimen	Bavarian Nordic A/S
08-Nov-2019	Bioeq announces Coherus as marketing and distribution partner for its biosimilar to Lucentis® (ranibizumab) in the U.S.	Bioeq
08-Nov-2019	OBN Awards 2019 – Winners Recognised at Industry Leading Event	OBN
07-Nov-2019	Combatting Counterfeiters	Neo PR Limited
07-Nov-2019	Signant Health Proud to Sponsor the Philadelphia Walk to End Alzheimer’s in Nationwide Effort to Build Awareness, Raise Funds and Advance Research Towards a Cure.	Signant Health
07-Nov-2019	Artios Pharma, MD Anderson and ShangPharma announce in-licensing agreement for DNA damage response inhibitor	Artios Pharma Limited
07-Nov-2019	Urania Therapeutics closes a €3.5M initial seed round	Advent France Biotechnology
07-Nov-2019	Freeline to present data on AAV-based gene therapies for Gaucher Disease and Haemophilia A at the 61st ASH Annual Meeting	Freeline
07-Nov-2019	Recent Advances in Bavarian Nordic’s Cancer Immunotherapy Platform Published in Nature Communications	Bavarian Nordic
07-Nov-2019	BERGENBIO’S BEMCENTINIB MEETS PRIMARY ENDPOINT IN FIRST COHORT OF PHASE 2 NSCLC STUDY IN COMBINATION WITH KEYTRUDA®	BerGenBio
07-Nov-2019	Medigene AG: Medigene präsentiert Poster zu Neoantigenen als Zielmolekül für zellbasierte TCR-T-Therapien auf SITC-Jahrestagung 2019	Medigene AG
07-Nov-2019	Medigene AG: Immune monitoring data from phase I/II clinical trial with DC vaccines in AML to be presented at ASH conference	Medigene AG
07-Nov-2019	Autolus Therapeutics to Present New Data on Its Advanced Programmed T Cell Therapies at the 61st ASH Annual Meeting	Autolus Therapeutics plc
07-Nov-2019	Summit Therapeutics to Participate in Panel Sessions at the World Antimicrobial Resistance Congress	Summit Therapeutics plc
07-Nov-2019	BC Platforms Opens New Entity in Singapore to Spearhead its Asia Pacific Strategy and Hosts Launch Event in Precision Medicine	BC Platforms
07-Nov-2019	PredictImmune and the Crohn’s & Colitis Foundation announce start of jointly-sponsored study to validate PredictSURE IBD™, the first prognostic test for IBD, in the US market	PredictImmune
07-Nov-2019	Hikma continues strong 2019 performance and reiterates full year guidance	Hikma Pharmaceuticals PLC